Pioglitazone and bladder cancer: two studies, same database, two answers.
作者信息
de Vries Frank, Zeegers Maurice, Goossens Maria E
机构信息
Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Centre +, Maastricht, the Netherlands; School CAPHRI, Maastricht University, Maastricht, the Netherlands; Department of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
出版信息
Br J Clin Pharmacol. 2013 Sep;76(3):484-5. doi: 10.1111/bcp.12145.
Abstract
摘要
相似文献
1
Pioglitazone and bladder cancer: two studies, same database, two answers.吡格列酮与膀胱癌：两项研究，同一数据库，两种答案。
Br J Clin Pharmacol. 2013 Sep;76(3):484-5. doi: 10.1111/bcp.12145.
2
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.噻唑烷二酮类药物治疗时间延长与膀胱癌风险的关系：一项队列研究。
J Natl Cancer Inst. 2012 Sep 19;104(18):1411-21. doi: 10.1093/jnci/djs328. Epub 2012 Aug 9.
3
Pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?吡格列酮与人类膀胱癌研究：是糖尿病本身、糖尿病药物、分析缺陷还是不同种族？
J Formos Med Assoc. 2012 Mar;111(3):123-31. doi: 10.1016/j.jfma.2011.10.003. Epub 2012 Feb 15.
4
Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study.吡格列酮与法国糖尿病患者膀胱癌风险：一项基于人群的队列研究。
Diabetologia. 2012 Jul;55(7):1953-62. doi: 10.1007/s00125-012-2538-9. Epub 2012 Mar 31.
5
Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis.吡格列酮治疗糖尿病患者膀胱癌风险增加：一项荟萃分析。
Diabetes Res Clin Pract. 2012 Oct;98(1):159-63. doi: 10.1016/j.diabres.2012.05.006. Epub 2012 Jun 16.
6
Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries.吡格列酮的使用与2型糖尿病患者膀胱癌风险：利用四个欧洲国家数据集的回顾性队列研究
BMJ. 2016 Aug 16;354:i3903. doi: 10.1136/bmj.i3903.
7
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study.吡格列酮的使用与 2 型糖尿病患者膀胱癌风险：巢式病例对照研究。
BMJ. 2012 May 30;344:e3645. doi: 10.1136/bmj.e3645.
8
Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue.制药行业歪曲药物安全性证据的案例：吡格列酮与膀胱癌问题
Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):212-4. doi: 10.1002/pds.3925. Epub 2015 Nov 30.
9
Pioglitazone use and the risk of bladder cancer.吡格列酮的使用与膀胱癌风险。
Kaohsiung J Med Sci. 2014 Feb;30(2):94-7. doi: 10.1016/j.kjms.2013.09.011. Epub 2013 Oct 29.
10
Observational follow-up of the PROactive study: a 6-year update.PROactive研究的观察性随访：6年更新
Diabetes Obes Metab. 2014 Jan;16(1):63-74. doi: 10.1111/dom.12180. Epub 2013 Aug 19.
引用本文的文献
1
Risk of bladder cancer in patients with diabetes: a retrospective cohort study.糖尿病患者患膀胱癌的风险：一项回顾性队列研究。
BMJ Open. 2015 Jun 1;5(6):e007470. doi: 10.1136/bmjopen-2014-007470.
本文引用的文献
1
Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data.接触双膦酸盐与胃肠道癌症风险：基于 QResearch 和 CPRD 数据的一系列巢式病例对照研究。
BMJ. 2013 Jan 16;346:f114. doi: 10.1136/bmj.f114.
2
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study.吡格列酮的使用与 2 型糖尿病患者膀胱癌风险：巢式病例对照研究。
BMJ. 2012 May 30;344:e3645. doi: 10.1136/bmj.e3645.
3
Pioglitazone and bladder cancer: a propensity score matched cohort study.吡格列酮与膀胱癌：一项倾向评分匹配队列研究。
Br J Clin Pharmacol. 2013 Jan;75(1):254-9. doi: 10.1111/j.1365-2125.2012.04325.x.
4
Bisphosphonates and cancer. Two studies, same data source, two answers.双膦酸盐与癌症。两项研究，同一数据来源，两种答案。
BMJ. 2010 Oct 26;341:c5980. doi: 10.1136/bmj.c5980.
5
Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers.
Osteoporos Int. 2011 May;22(5):1641-2. doi: 10.1007/s00198-010-1323-1. Epub 2010 Jun 19.
6
Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database.对两项关于他汀类药物使用与骨折风险关联的结果相互矛盾的研究进行再分析：全科医学研究数据库。
Int J Epidemiol. 2006 Oct;35(5):1301-8. doi: 10.1093/ije/dyl147.
7
Severity of obstructive airway disease and risk of osteoporotic fracture.阻塞性气道疾病的严重程度与骨质疏松性骨折风险
Eur Respir J. 2005 May;25(5):879-84. doi: 10.1183/09031936.05.00058204.
Zotero 插件